MetaCap

Braveheart Bio Statistics

NASDAQ: BRVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

20.39+1.12 (+5.81%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Braveheart Bio by the numbers

Braveheart Bio has a market capitalization of $1.67 billion based on 82.07M shares outstanding. With trailing EPS of $-6.59, Braveheart Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.9% below its 50-day average and 12.6% below its 200-day average.

Average daily trading volume is 491.27K shares, or about $10.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BRVE valuation vs. peer median

BRVE compared with the median of 8 peer companies
MetricBRVEPeer medianDifference
Market cap$1.67B$1.72B-2%
Avg. volume491.27K922.18K-47%

Peer median across 8 companies: RARE, AGIO, KRSA, SDGR, ZBIO, TRAX, STOK, ETON.

Valuation

Price and trading

Previous close
19.27
Open
19.29
Day range
18.83 – 21.11
52-week range
16.70 – 32.00
Beta
—
Volume
866.73K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.67B
Forward Pe
-10.25
Eps
-6.59
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
32.00
Week52 Low
16.70
Avg Volume
491.27K
Shares Outstanding
82.07M
Ma50
21.23
Ma200
23.33
Earnings Date
Dec 8, 2026
Pct From52w High
-36.28%
Pct From52w Low
22.10%

Related